6505--Hydralazine RFP
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36E79725R0060
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The VA National Acquisition Center is seeking proposals for the supply of Hydralazine tablets in multiple dosage strengths and bottle sizes through an unrestricted competitive procurement. The procurement serves the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. Offerors must provide an exact drug name matching the label, possess a unique NDC number, and ensure packaging in non-glass bottles to meet government specifications. The solicitation will be issued in commercial item format under FAR Part 12 on or about October 22, 2025, with a tentative closing date of November 5, 2025. All solicitation documents will be available exclusively through SAM.gov in electronic format, with no paper copies provided. Interested vendors should direct questions to Amber Zavala at amber.zavala@va.gov and monitor SAM.gov continuously for any amendments or changes to the solicitation.
This is an unrestricted procurement with no set-aside designations, meaning all responsible sources are eligible to submit proposals. The contract will be awarded to a single responsible offeror capable of providing an uninterrupted supply and will run for one year with four additional pre-priced one-year option periods for a potential five-year total contract duration. Estimated annual requirements span multiple Hydralazine HCl formulations, including 100mg tablets (103,773 bottles), 50mg tablets (5,481 bottles), 25mg tablets in both 100-count and 1000-count bottles (6,188 and 29,343 respectively), and 10mg tablets in similar configurations (6,279 and 12,283 bottles). The contract items will be distributed through the VA and DOD Pharmaceutical Prime Vendor Programs. No incumbent contractor information or specific award value is disclosed in the pre-solicitation notice.
Notice text
Page 2 of 2
Page 2 of 2
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79725R0060 for an unrestricted procurement for Hydralazine tablets, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Glass bottles are not acceptable. Solicitation # 36E79725R0060 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about 10/22/2025 with a tentative closing date of 11/05/2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Amber Zavala. Questions can be e-mailed to: amber.zavala@va.gov.
The estimated annual requirements are as follows:
Description Size Estimated Annual Requirements (Bottle)
HYDRALAZINE HCL 100MG TAB 100 103,773
HYDRALAZINE HCL 10MG TAB 100 6,279
HYDRALAZINE HCL 10MG TAB 1000 12,283
HYDRALAZINE HCL 25MG TAB 100 6,188
HYDRALAZINE HCL 25MG TAB 1000 29,343
HYDRALAZINE HCL 50MG TAB 100 5,481
HYDRALAZINE HCL 50MG TAB 1000 28,046
Files
| File | Type | Posted |
|---|---|---|
| 36E79725R0060_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Hydralazine HCL Tablets Effective 04/08/2026 to 04/07/2027 | Award Notice | |
| 6505--Hydralazine RFP | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| 6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 | Veterans Integrated Service Network 10 | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity